Evidence map›Paper›PMID 40993121›Full record

ArticleNature communications2025

GPS Pipeline: portable, scalable genomic pipeline for Streptococcus pneumoniae surveillance from Global Pneumococcal Sequencing Project.

Harry C H Hung, Narender Kumar, Victoria Dyster, Corin Yeats, Benjamin Metcalf, Yuan Li, Paulina A Hawkins, Lesley McGee, Stephen D Bentley, Stephanie W Lo

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A mini review of genome-predicted β-lactam susceptibility inFrontiers in cellular and infection microbiology · 2026
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Harry C H HungParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK. ch31@sanger.ac.uk.ORCID http://orcid.org/0009-0005-3857-5242
Narender KumarParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Victoria DysterParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Corin YeatsCentre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0080-6242
Benjamin MetcalfDivision of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, USA.ORCID http://orcid.org/0000-0002-9628-2051
Yuan LiDivision of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, USA.ORCID http://orcid.org/0000-0002-2331-2694
Paulina A HawkinsDivision of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, USA.ORCID http://orcid.org/0000-0001-5096-392X
Lesley McGeeDivision of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, USA.ORCID http://orcid.org/0000-0001-8214-921X
Stephen D BentleyParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-8094-3751
Stephanie W LoParasites and Microbes, Wellcome Sanger Institute, Hinxton, UK. sl28@sanger.ac.uk.ORCID http://orcid.org/0000-0002-2182-0222

Funding

Gates Foundation INV-003570Wellcome TrustWellcome Trust 206194
6 · The paper itself

Abstract

Streptococcus pneumoniae (pneumococcus) is a major pathogen globally, responsible for an estimated one million deaths annually and contributing significantly to the global burden of antimicrobial resistance. Ongoing surveillance of its vaccine antigen (i.e. serotypes), antimicrobial resistance, and pneumococcal lineages is crucial for assessing the impact of vaccination programs and guiding future vaccine design. However, current bioinformatics tools have several limitations that prevent them from enabling comprehensive analysis that allows simultaneous, large-scale, and independent generation of these crucial data. Here, we present the GPS Pipeline that enables reliable extraction of public health information from pneumococcal genomes using in silico methods. It can accurately identify 102 of 107 known serotypes, recognise 1053 pneumococcal lineages, and predict susceptibilities to 19 common antibiotics. Built on Nextflow and utilising containerisation technology, the GPS Pipeline minimises software setup requirements and bioinformatics expertise while facilitating large-scale analysis of genomic data. The GPS Pipeline was applied and validated on 20,924 pneumococcal genomes worldwide, demonstrating its effectiveness in enhancing responsiveness in pneumococcal genomic surveillance.

Indexed as

Genome, BacterialGenomicsPneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsComputational BiologyHumansPneumococcal VaccinesSerogroupSoftwareAnti-Bacterial AgentsPneumococcal Vaccines

Identifiers

PMID40993121
PMCPMC12460886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.